The 340B Drug Pricing Program

Oversight and Investigations Subcommittee Hearing: “Oversight of 340B Drug Pricing Program”

340B Drug Pricing Program Compliance | JD Supra

Perspectives on the 340B Drug Pricing Program | The U.S. Senate Committee on Health, Education, Labor & Pensions

What is 340B and how does it impact hospitals’ bottom line?

The federal 340B program requires drug makers to sell their products to some hospitals at a discount. Hospitals and contract pharmacies can then resell them and pocket the difference. It’s a case of the government picking winners (hospitals) and losers (drug manufacturers) among private market participants. Hospitals argue that they need the money to help patients. That is, they use the extra revenue from the program to cut costs or provide free care for those in need. But Jarrett Skorup of the

11 reactions | Taxpayers are footing the bill for the 340B Drug Pricing Program. Hospitals, contract pharmacies, and special interest sharks are profiting. They’re taking advantage of 340B discounts meant for patients, and it’s costing taxpayers. We can fix the mess if Congress reforms the program. https://www.cagw.org/340B #Fix340B | Citizens Against Government Waste | Facebook

15 reactions | Special interest sharks are feeding off of the 340B Drug Pricing Program at the expense of patients. Stop the feeding frenzy and give patients the drug discounts they deserve. Fix the mess! https://www.cagw.org/340B #Fix340B | Citizens Against Government Waste | Facebook